Pelicci Pain Relief Center Scranton, PA - 18510

Pelicci Pain Relief Center is categorized under Neurologists in Scranton, PA and active since 1980.

Pelicci Pain Relief Center was established in 1980, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact Tim Gusi, Manager at the company’s single location by writing to 748 Quincy Avenue # 301b, Scranton, Pennsylvania PA 18510 or by phoning (570) 342-8633. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pelicci Pain Relief Center
Contact Person: Tim Gusi, Manager
Address: 748 Quincy Avenue # 301b, Scranton, Pennsylvania 18510
Phone Number: (570) 342-8633
Website Address: peliccipainrelief.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 1980
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Neurologists
SIC Code: 8011
NAICS Code: 6215110
Share This Business:

Pelicci Pain Relief Center was started in 1980 to provide professional Neurologists under the SIC code 8011 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Tim Gusi, Manager for inquiries that concern Pelicci Pain Relief Center by calling the company number (570) 342-8633, as your correspondence is most welcome. Additionally, the physical location of the single location of Pelicci Pain Relief Center can be found at the coordinates 41.41076,-75.65063 as well as the street address 748 Quincy Avenue # 301b in Scranton, Pennsylvania 18510.

For its online presence, you may visit Pelicci Pain Relief Center’s website at peliccipainrelief.com and engage with its social media outlets through on Twitter and on Facebook.